Cardio‐Kidney‐Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease
CKM therapy was frequently used in patients with Type 1 diabetes and CKD, associated with UACR reduction and safe. These clinically relevant data warrant confirmation in randomised clinical trials.
Authors
- Christopher Perkins
- M. Luiza Caramori
- Enrico Repetto
- Peter Rossing
- Ambarish Pandey
Institutions
- University of Copenhagen (DK)
- Cleveland Clinic (US)
- Steno Diabetes Centers (DK)
- Cleveland Foundation (US)
- Rolls-Royce (United States) (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1111/dom.70640
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00